Bempedoic acid, sold under the brand name Nexletol among others, is a medication for the treatment of hypercholesterolemia (high blood cholesterol levels)...
19 KB (1,599 words) - 00:19, 28 November 2023
of bempedoic acid and ezetimibe. The most common side effects are hyperuricemia (high blood levels of uric acid) and constipation. Bempedoic acid is an...
9 KB (748 words) - 06:58, 1 April 2024
Bempedoic acid/ezetimibe/atorvastatin is a combination therapy composed of bempedoic acid, ezetimibe, and atorvastatin. In a randomized study it showed...
2 KB (200 words) - 12:55, 4 January 2024
traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels...
6 KB (569 words) - 12:24, 18 May 2024
ezetimibe/simvastatin, ezetimibe/atorvastatin, ezetimibe/rosuvastatin, and ezetimibe/bempedoic acid. The most commonly reported adverse events include upper respiratory...
20 KB (1,818 words) - 13:12, 17 May 2024
www.accessdata.fda.gov. Retrieved 2021-07-01. "DailyMed - NEXLETOL- bempedoic acid tablet, film coated". dailymed.nlm.nih.gov. Retrieved 2021-07-01. "Tafamidis...
11 KB (842 words) - 13:15, 12 February 2024
(available only in Japan) Nilemdo (bempedoic acid, only sold in the EU) Nustendi (fixed dose combination of bempedoic acid and ezetimibe) Other Canalia (teneligliptin...
29 KB (2,326 words) - 13:59, 3 May 2024
transfer protein (MTP) which results in a reduction of LDL plasma levels. Bempedoic acid acts on the cholesterol synthesis pathway upstream of statins at ATP...
30 KB (2,959 words) - 11:26, 19 May 2024
ATC code C10 (section C10AC Bile acid sequestrants)
Alirocumab C10AX15 Bempedoic acid C10AX16 Inclisiran C10AX17 Evinacumab C10AX18 Volanesorsen C10BA01 Lovastatin and nicotinic acid C10BA02 Simvastatin...
4 KB (434 words) - 04:44, 18 December 2023
(approved by the FDA in 2013 homozygous familial hypercholesterolemia.). Bempedoic acid, an ATP citrate lyase inhibitor ATC code C10 Alenghat, Francis J.; Davis...
11 KB (1,251 words) - 18:05, 19 February 2024